| 61 |
PRADOX 100 |
TOPIRAMATE MICRONIZED 100 MG |
FILM COATED TABLET |
ALU-ALU |
MONOTHERAPY IN ADULTS, ADOLESCENTS AND CHILDREN OVER 6 YEARS OF AGE WITH PARTIAL SEIZURES WITH OR WITHOUT SECONDARY GENERALISED SEIZURES AND PRIMARY GENERALIZED TONIC CLONIC SEIZURES, ADJUNCTIVE THERAPY IN CHILDREN AGED 2 YEARS AND ABOVE, ADOLESCENTS AND ADULTS WITH PARTIAL ONSET SEIZURES WITH OR WITHOUT SECONDARY GENERALISED SEIZURES AND PRIMARY GENERALIZED TONIC CLONIC SEIZURES AND FOR THE TREATMENT OF SEIZURES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
10 I 5292/22 |
14-Oct-2022 |
13-Oct-2025 |
View |
| 62 |
PRADOX 25 |
TOPIRAMATE MICRONIZED 25 MG |
FILM COATED TABLET |
ALU-ALU |
MONOTHERAPY IN ADULTS, ADOLESCENTS AND CHILDREN OVER YEARS OF AGE WITH PARTIAL SEIZURES WITH OR WITH SECONDARY GENERALIZED, PRIMARY GENERALISED TONIC-CLONIC SEIZURES, AGJUNCTIVE THERAPY IN CHILDREN AGED 2 YEARS AND ABOVE, ADOLESCENTS AND ADULTS WITH PARTIAL ONSET SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION OR PRIMARY GENERALISED TONIC-CLINIC SEIZURES AND FOR THE TREATMENT OF SEIZURES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
10 I 5293/22 |
14-Oct-2022 |
13-Oct-2025 |
View |
| 63 |
PRADOX 50 |
TOPIRAMATE MICRONIZED 50 MG |
FILM COATED TABLET |
ALU-ALU |
MONOTHERAPY IN ADULTS, ADOLESCENTS AND CHILDREN OVER 6 YEARS OF AGE WITH PARTIAL SEIZURES WITH OR WITHOUT SECONDARY GENERALISED SEIZURES AND PRIMARY GENERALIZED TONIC CLONIC SEIZURES, ADJUNCTIVE THERAPY IN CHILDREN AGED 2 YEARS AND ABOVE, ADOLESCENTS AND ADULTS WITH PARTIAL ONSET SEIZURES WITH OR WITHOUT SECONDARY GENERALISED SEIZURES AND PRIMARY GENERALIZED TONIC CLONIC SEIZURES AND FOR THE TREATMENT OF SEIZURES ASSOCIATED WITH LENNOX-GASTAUT SYNDROME |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
10 I 5294/22 |
14-Oct-2022 |
13-Oct-2025 |
View |
| 64 |
PRESOLIN 150 |
IRBESARTAN 150 MG |
TABLET |
ALU-PVC/PVDC |
HYPERTENSION, DIABETIC NEUROPATHY WITH AN ELEVATED SRCR AND PROTEINURIA(>300 MG'/DAY) IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
06 I 4710/19 |
5-AUG-2022 |
4-AUG-2025 |
View |
| 65 |
PRESOLIN 300 |
IRBESARTAN 300 MG |
TABLET |
ALU-PVC/PVDC |
HYPERTENSION, DIABETIC NEUROPATHY WITH AN ELEVATED SRCR AND PROTEINURIA(>300 MG'/DAY) IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
06 I 4711/19 |
5-AUG-2022 |
4-AUG-2025 |
View |
| 66 |
QUANTIA 100 |
QUETIAPINE FUMARATE 115.13 MG EQ.TO QUETIAPINE 100 MG |
FILM-COATED TABLETS |
ALU-PVC/PVDC |
TREATMENT OF SCHIZOPHRENIA IN ADULT AND ADOLESCENTS(13-17 YEARS OF AGE), ACUTE TREATMENT OF MANIC EPISODES ASSOCIATED WITH BIPOLAR 1 DISORDERS, TREATMENT OF DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR DISORDERS, MAINTENANCE TREATMENT OF BIPOLAR1 DISORDERS |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
04 I 4400/18 |
2025-01-09 |
2030-01-08 |
View |
| 67 |
QUANTIA 200 |
QUETIAPINE FUMARATE 230.260 MG EQ.TO QUETIAPINE 200 MG |
FILM-COATED TABLETS |
ALU-PVC/PVDC |
TREATMENT OF SCHIZOPHRENIA IN ADULT AND ADOLESCENTS(13-17 YEARS OF AGE), ACUTE TREATMENT OF MANIC EPISODES ASSOCIATED WITH BIPOLAR 1 DISORDERS, TREATMENT OF DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR DISORDERS, MAINTENANCE TREATMENT OF BIPOLAR1 DISORDERS |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
04 I 4401/18 |
2025-01-09 |
2030-01-08 |
View |
| 68 |
QUANTIA 25 |
QUETIAPINE FUMARATE 28.7825 MG EQ.TO QUETIAPINE 25 MG |
FILM-COATED TABLETS |
ALU-PVC/PVDC |
TREATMENT OF SCHIZOPHRENIA IN ADULT AND ADOLESCENTS(13-17 YEARS OF AGE), ACUTE TREATMENT OF MANIC EPISODES ASSOCIATED WITH BIPOLAR 1 DISORDERS, TREATMENT OF DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR DISORDERS, MAINTENANCE TREATMENT OF BIPOLAR1 DISORDERS |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
04 I 4399/18 |
2025-01-09 |
2030-01-08 |
View |
| 69 |
RE-B FORTE |
THIAMINE MONONITRATE 250 MG, PYRIDOXINE HYDROCHLORIDE 250 MG, CYANOCOBALAMIN 1000 MCG |
FILM-COATED TABLETS |
ALU-ALU BLISTER |
FOR PREVENTION AND TREAMENT OF THIAMINE, PYRIDOXINE AND CYANOCOBALAMIN DEFICIENCY STATES. |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
05 I 3354/09 |
16-DEC-2024 |
15-DEC-2029 |
View |
| 70 |
SISALON 50 |
SERTRALINE HCL 55.95 MG EQ.TO SERTRALINE 50 MG |
FILM-COATED TABLETS |
ALU-ALU BLISTERPACK |
MAJOR DEPRESSIVE EPISODES, PREVENTION OF RECURRENCE OF MAJOR DEPRESSIVE EPISODES, PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA, OBSESSIVE COMPULSIVE DISORDER IN ADULTS AND PEDIATRIC PATIENTS AGED 6-17 YEARS, SOCIAL ANXIETY DISORDER, POST TRAUMATIC STRESS D |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
12 I 4880/19 |
2-Feb-2023 |
01-Feb-2026 |
View |
